• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两名I型克里格勒-纳贾尔综合征患者肝脏微粒体中双氯芬酸、(-)-吗啡、4-硝基苯酚和丙泊酚的葡萄糖醛酸化作用

Glucuronidation of diflunisal, (-)-morphine, 4-nitrophenol, and propofol in liver microsomes of two patients with Crigler-Najjar syndrome type I.

作者信息

Brunelle F M, Raoof A A, de ville de Goyet J, Verbeeck R K

机构信息

Pharmacokinetics Laboratory, School of Pharmacy, University Hospital St. Luc, Catholic University of Louvain, Brussels, Belgium.

出版信息

Biopharm Drug Dispos. 1996 May;17(4):311-7. doi: 10.1002/(SICI)1099-081X(199605)17:4<311::AID-BDD953>3.0.CO;2-V.

DOI:10.1002/(SICI)1099-081X(199605)17:4<311::AID-BDD953>3.0.CO;2-V
PMID:8743402
Abstract

In vitro glucuronidation was studied in liver microsomes from two patients with Crigler-Najjar type I (CN-I) disease and compared with the activity measured in microsomes prepared from six control human livers. The UDP-glucuronosyltransferase (UGT) activity was determined toward the following substrates: 4-nitrophenol, propofol, (-)-morphine (formation of the 3-glucuronide), and diflunisal (formation of the phenolic and acyl glucuronides). Glucuronidation of 4-nitrophenol was reduced in one of the CN-I livers (CN-I No. 1) (0.9 nmol min(-1)mg(-1)) and normal in the other CN-I liver (CN-I No. 2) (3.5 nmol min(-1) mg(-l)) compared to the control livers (5.6 +/- 29 nmol min(-1) mg(-1)), mean +/- S.D.). Propofol glucuronidation was not detectable (i.e. less than 0.100 nmol min(-l) mg(-1) in the CN-I No. 1 liver and normal in the CN-I No. 2 liver (1.78 nmol min(-1) mg(-1) against 1.52 +/ 0.72 nmol min(-l) mg(-) in the control livers). The glucuronidation of (-)-morphine to the 3-glucuronide and the formation of the phenolic and acyl glucuronides of diflunisal were normal in both CN-I livers compared to the control livers. Our results show that CN-I patients are heterogeneous regarding UGT activity toward the phenolic substances 4-nitrophenol and propofol.

摘要

在两名患有I型克里格勒 - 纳贾尔综合征(CN - I)的患者的肝微粒体中研究了体外葡萄糖醛酸化作用,并与从六个对照人肝脏制备的微粒体中测得的活性进行了比较。测定了UDP - 葡萄糖醛酸基转移酶(UGT)对以下底物的活性:4 - 硝基苯酚、丙泊酚、( - ) - 吗啡(3 - 葡萄糖醛酸苷的形成)和双氯芬酸(酚类和酰基葡萄糖醛酸苷的形成)。与对照肝脏(5.6±2.9 nmol min⁻¹mg⁻¹,平均值±标准差)相比,4 - 硝基苯酚的葡萄糖醛酸化在其中一个CN - I肝脏(CN - I No.1)中降低(0.9 nmol min⁻¹mg⁻¹),而在另一个CN - I肝脏(CN - I No.2)中正常(3.5 nmol min⁻¹mg⁻¹)。丙泊酚的葡萄糖醛酸化在CN - I No.1肝脏中无法检测到(即低于0.100 nmol min⁻¹mg⁻¹),在CN - I No.2肝脏中正常(1.78 nmol min⁻¹mg⁻¹),对照肝脏中为1.52±0.72 nmol min⁻¹mg⁻¹。与对照肝脏相比,在两个CN - I肝脏中,( - ) - 吗啡向3 - 葡萄糖醛酸苷的葡萄糖醛酸化以及双氯芬酸的酚类和酰基葡萄糖醛酸苷的形成均正常。我们的结果表明,CN - I患者在UGT对酚类物质4 - 硝基苯酚和丙泊酚的活性方面存在异质性。

相似文献

1
Glucuronidation of diflunisal, (-)-morphine, 4-nitrophenol, and propofol in liver microsomes of two patients with Crigler-Najjar syndrome type I.两名I型克里格勒-纳贾尔综合征患者肝脏微粒体中双氯芬酸、(-)-吗啡、4-硝基苯酚和丙泊酚的葡萄糖醛酸化作用
Biopharm Drug Dispos. 1996 May;17(4):311-7. doi: 10.1002/(SICI)1099-081X(199605)17:4<311::AID-BDD953>3.0.CO;2-V.
2
Glucuronidation of R- and S-ketoprofen, acetaminophen, and diflunisal by liver microsomes of adjuvant-induced arthritic rats.佐剂诱导性关节炎大鼠肝微粒体对R-和S-酮洛芬、对乙酰氨基酚及二氟尼柳的葡萄糖醛酸化作用
Drug Metab Dispos. 1999 Jan;27(1):26-31.
3
In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.使用人肝微粒体和孔形成肽阿拉霉素进行体外葡萄糖醛酸化反应。
Drug Metab Dispos. 2000 May;28(5):560-6.
4
Glucuronidation of diflunisal in liver and kidney microsomes of rat and man.大鼠和人肝脏及肾脏微粒体中双氟芬酸的葡萄糖醛酸化作用。
Xenobiotica. 1996 Feb;26(2):123-31. doi: 10.3109/00498259609046694.
5
N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II.抗癫痫药物瑞替加滨的N-葡萄糖醛酸化:来自人类志愿者、异源表达的人类尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)、人肝脏、肾脏以及II型克里格勒-纳贾尔综合征患者肝脏微粒体膜研究的结果
Metabolism. 2006 Jun;55(6):711-21. doi: 10.1016/j.metabol.2006.01.006.
6
A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.一种在V79细胞中稳定表达的重组苯巴比妥诱导型大鼠肝脏UDP-葡萄糖醛酸基转移酶(UDP-葡萄糖醛酸基转移酶2B1)催化吗啡、酚类和羧酸的葡萄糖醛酸化反应。
Mol Pharmacol. 1994 Jan;45(1):42-50.
7
Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.表柔比星葡萄糖醛酸化由人尿苷二磷酸葡萄糖醛酸基转移酶2B7催化。
Drug Metab Dispos. 2001 May;29(5):686-92.
8
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.UDP对UDP-葡萄糖醛酸基转移酶(UGT)的产物抑制作用掩盖了UGT底物的抑制效果。
Drug Metab Dispos. 2008 Feb;36(2):361-7. doi: 10.1124/dmd.107.018705. Epub 2007 Nov 12.
9
Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.多巴胺的区域选择性葡萄糖醛酸化:显著的物种差异及人尿苷二磷酸葡萄糖醛酸基转移酶同工型的鉴定
Drug Metab Dispos. 2005 Mar;33(3):403-12. doi: 10.1124/dmd.104.002667. Epub 2004 Dec 17.
10
The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1.稳定表达的大鼠和人尿苷二磷酸葡萄糖醛酸基转移酶1.1对外源性和内源性化合物的葡萄糖醛酸化作用
Arch Biochem Biophys. 1996 Aug 1;332(1):92-100. doi: 10.1006/abbi.1996.0320.